Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12

Status unconfirmed

Conditions studied: Breast Cancer

In brief

The purpose of this study is to measure the level of AlloMax™ incorporation (cellular infiltration, collagen production, and neovascularization) in human breast reconstruction. The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast capsule at the 3-4 month time point.

Key facts

Study ID

NCT01679223

Run by

University of Nevada, Las Vegas

People needed

60

Starts

2014-02-01

Expected to finish

2018-11-01

Last updated by the study team

2015-01-09

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (18 - 70 yrs) who require reconstructive breast surgery with AlloMaxTM implants and agree to participate will be included in this study.

You may not qualify if…

• Patients who do not agree to be included in the study.

Where it is running

• University of Nevada School of Medicine — Las Vegas, Nevada, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.